A Phase 3 efficacy, safety and tolerability study of zolbetuximab (experimental drug) plus mFOLFOX6 chemotherapy compared to placebo plus mFOLFOX6 as treatment for gastric and gastroesophageal junction (GEJ) cancer

Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2018
This article has no abstract
Epistemonikos ID: ffe8727bf81850f23a2d32be281dd234e60e814a
First added on: Apr 11, 2025